These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20299412)
1. Which lipid fraction is the target and how often should this be monitored? Thompson G Heart; 2010 Mar; 96(6):413-4. PubMed ID: 20299412 [No Abstract] [Full Text] [Related]
2. Coronary risk factor intervention--a review of physical activity and serum lipids. Garman JF Am Correct Ther J; 1978; 32(6):183-9. PubMed ID: 371376 [No Abstract] [Full Text] [Related]
3. [Lipids and arteriosclerosis]. Carmena R Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566 [No Abstract] [Full Text] [Related]
4. [Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations]. Mayer O; Mayer O Vnitr Lek; 2004 Oct; 50(10):777-80. PubMed ID: 15633934 [TBL] [Abstract][Full Text] [Related]
5. Management of dyslipidemia. Akel MM; Salti I J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421 [No Abstract] [Full Text] [Related]
6. Serum lipids and lipoproteins in first degree relatives of young survivors of myocardial infarction. Aro A Acta Med Scand Suppl; 1973; 553():1-103. PubMed ID: 4550038 [No Abstract] [Full Text] [Related]
7. [Lipid determination in current medical practice]. Bakir R; Chanu B; Rouffy J Ann Dermatol Venereol; 1986; 113(9):855-9. PubMed ID: 3827091 [No Abstract] [Full Text] [Related]
9. [Plasma lipids in normal subjects, and in patients with coronary disease and peripheral arteriopathy]. Rusconi C; Gola E; Arosio G; Riva S; Frau G; Albertini A; Prandini BD; Spandrio L Minerva Med; 1973 Nov; 64(80):4209-16. PubMed ID: 4765428 [No Abstract] [Full Text] [Related]
10. [Plasma lipid and lipoprotein levels among rural and urban populations in Poland in relation to risk factors of coronary disease]. Pajak A; Broda G; Sznajd J; Rywik S; Jamska B; Chodkowska E; Czarnecka H; Bednarska M; Rostworowski W; Kurjata P Przegl Lek; 1990; 47(5):454-8. PubMed ID: 2267364 [TBL] [Abstract][Full Text] [Related]
11. [The risk and treatment of hyperlipoproteinemias]. Alzamora P; Alegría E; Iglesias I Rev Med Univ Navarra; 1990; 34(1):29-30, 32-5, 37-40. PubMed ID: 2096448 [TBL] [Abstract][Full Text] [Related]
12. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Adv Intern Med; 1997; 42():1-38. PubMed ID: 9048115 [No Abstract] [Full Text] [Related]
13. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)? Sherrod JP; Krist A J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006 [No Abstract] [Full Text] [Related]